SCHEMBL8669232

SCHEMBL8669232

c1ccc(C[C](c2ccccc2)C2CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.46
LMNA P02545 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
KMT2A Q03164 2/20 0.41
EPHX2 P34913 1/20 0.41
MEN1 O00255 1/20 0.41
HTR2A P28223 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
S1PR5 Q9H228 2/20 0.37
PAM P19021 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9130807 0.92 ALDH1A1 (0.46) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL11504283 0.92 EPHX2 (0.46) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL8894515 0.76 ALDH1A1 (0.42) KMT2AALDH1A1HPGD
SCHEMBL7368098 0.76 LMNA (0.49) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL7370889 0.74 SCN1A (0.44) AKR1B1LMNAL3MBTL1KMT2AMEN1
SCHEMBL10519134 0.73 ATM (0.41) LMNACES2CES1KMT2AMEN1
SCHEMBL1155730 0.72 FAAH (0.55) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL17801467 0.72 LMNA (0.46) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL12950567 0.72 L3MBTL1 (0.47) AKR1B1LMNAL3MBTL1CES2CES1
SCHEMBL3587635 0.72 POLB (0.41) LMNACES2CES1KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997021678-A1 CARBAMIC ACID DERIVATIVES AS LEUKOTRIENE ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 1997-06-19 WO claimed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
EP-0572547-A1 SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-12-08 EP disclosed